Oncologix Tech Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Oncologix Tech's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 May 2015 |
Recent past performance updates
No updates
Recent updates
No updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Oncologix Tech has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How Oncologix Tech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 May 15 | 5 | -2 | 2 | 0 |
| 28 Feb 15 | 4 | -1 | 1 | 0 |
| 30 Nov 14 | 4 | -2 | 1 | 0 |
| 31 Aug 14 | 4 | -1 | 1 | 0 |
| 31 May 14 | 3 | -2 | 1 | 0 |
| 28 Feb 14 | 2 | -1 | 1 | 0 |
| 30 Nov 13 | 1 | -1 | 1 | 0 |
| 31 Aug 13 | 0 | -1 | 0 | 0 |
| 31 May 13 | 0 | 0 | 0 | 0 |
Quality Earnings: Insufficient data to determine if OCLG has high quality earnings.
Growing Profit Margin: Insufficient data to determine if OCLG's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if OCLG's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare OCLG's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if OCLG's earnings growth over the past year exceeded the Healthcare industry average.
Return on Equity
High ROE: OCLG has a negative Return on Equity (0%), as it is currently unprofitable.